Skip Navigation


NDT Advance Access originally published online on April 4, 2007
Nephrology Dialysis Transplantation 2007 22(8):2136-2137; doi:10.1093/ndt/gfm180
This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow All Versions of this Article:
22/8/2136    most recent
gfm180v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Ruilope, L. M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Ruilope, L. M.
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

© The Author [2007]. Published by Oxford University Press on behalf of ERA-EDTA. All rights reserved. For Permissions, please email: journals.permissions@oxfordjournals.org

Renal AT 1 receptors and hypertension*

Luis M. Ruilope

Hypertension Unit, Hospital 12 de Octubre, Madrid, Spain

Correspondence and offprint requests to: Prof. Luis Ruilope, Hypertension Unit, Hospital 12 de Octubre, Madrid, Spain. Email: ruilope@ad-hocbox.com

Keywords: angiotensin II; arterial hypertension; AT1 receptor; kidney; left ventricular hypertrophy; natriuresis

The first 10% of the full text of this article appears below.

Arterial hypertension participates actively in the development and progression of cardiovascular risk (CVR). The kidney plays a double role of culprit in the development of arterial hypertension and victim, when it suffers the consequences of persistently elevated blood pressure. On the other hand, it has been clearly demonstrated that as soon as the kidney is damaged by arterial hypertension, there is a concomitant rise in global CVR that accounts for an enhanced prevalence of fatal and non-fatal cardiovascular events currently observed in patients with chronic kidney disease . . . [Full Text of this Article]


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?